ACPP Antibody, anti-human, REAdye_lease™
Synonyms: PAP (Prostatic Acid Phosphatase), 5'-NT, Ecto-5'-nucleotidase, TMPase, PAPf39
RECOMBINANT
Clone:
REAL717
Type of antibody:
Releasable fluorochromes, Primary antibodies, Recombinant antibodies
Applications:
MICS, IF, IHC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:

Related products for ACPP Antibody, anti-human, REAdye_lease™

MICS (MACSima Imaging Cyclic Staining) applications
FITC
PE
Fixation:
FFPE
Species tested:
human
Tissue used:
prostate
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
FITC
Used products:
130-126-572
Testing grade:
Description:
Immunofluorescence analysis of a formalin-fixed, paraffin embedded (FFPE) human prostate. Before staining, antigens were retrieved using heat-induced epitope retrieval (HIER) at pH 9. The section was stained using ACPP Antibody, anti-human, FITC (green) for 10 min at room temperature (A). ACPP Antibody, anti-human, FITC staining was released using the REAlease Release Reagent (B). Nuclei were visualized with Hoechst™ (blue). Scale bar: 30 µm.

A

Application imageView details view details

B

Application imageView details view details
Specifications for ACPP Antibody, anti-human, REAdye_lease™
Overview

Clone REAL717 is an antibody fragment derived from the full ACPP antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAdye_lease Complex to bind markers with high avidity.

Clone REAL717 recognizes the human ACPP (acid phosphatase, prostate), also known as PAP (prostatic acid phosphatase. ACPP is a non-specific tyrosine phosphatase that dephosphorylates a diverse number of substrates under acidic conditions. ACPP has lipid phosphatase activity and inactivates lysophosphatidic acid in seminal plasma. Isoform 2 of ACPP acts as a tumor suppressor of prostate cancer through dephosphorylation of ERBB2 and deactivation of MAPK-mediated signaling. It also generates adenosine from AMP which acts as a pain suppressor.

For removal of REAdye_lease fluorochromes for optional relabeling with different fluorochrome-conjugated REAdye_lease antibodies use the REAlease Support Kit (130-120-675).

Alternative names

PAP (Prostatic Acid Phosphatase), 5'-NT, Ecto-5'-nucleotidase, TMPase, PAPf39

Detailed product information

Technical specifications

Clone
REAL717
Clonality
monoclonal
Isotype control
Control Antibody
Host
cell line
Type of antibody
Releasable fluorochromes, Primary antibodies, Recombinant antibodies
Species reactivity
human
Antigen
ACPP
Distribution of antigen
prostate cancer cells, prostate
RRID
AB_2904625, AB_2904624
Resources for ACPP Antibody, anti-human, REAdye_lease™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

Citations for ACPP Antibody, anti-human, REAdye_lease™
Publications
  1. Graddis, T. J. et al. (2011) Prostatic acid phosphatase expression in human tissues. Int J Clin Exp Pathol 4 (3): 295-306
  2. Veeramani, S. et al. (2005) Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer. Endocr Relat Cancer 12 (4): 805-822